目的探讨组蛋白去乙酰化酶2(histone deacetylase 2,HDAC2)水平与突发性聋(sudden sensorineural hearing loss,SSNHL)患者糖皮质激素(glucocorticoid,GC)抵抗的关系。方法选择难治性SSNHL患者20例,所有患耳鼓室内灌注甲强龙20mg/d,连续10天,同时辅以全身静脉滴注营养神经及改善微循环药物。对照组为10例正常听力志愿者。分离所有研究对象的外周血单个核细胞(peripheral blood mononuclear cell,PBMC),提取细胞核蛋白以及总RNA,分别用HDAC2活性检测试剂盒以及real time PCR的方法,检测受试者PBMC中HDAC2的蛋白活性以及HDAC2mRNA的表达情况,并随访SSNHL患者听力,根据听力恢复情况将SSNHL患者分为GC有效组和GC无效组,探讨HDAC2水平与GC抵抗的关系。结果 20例SSNHL患者中,GC有效8例,GC无效12例,治疗前GC有效组及无效组患耳PTA分别为75.21±9.44和80.98±12.73dB HL,治疗后分别为40.83±14.37和77.92±12.25dB HL;治疗前突聋患者HDAC2蛋白活性OD值(GC有效组0.664±0.022,GC无效组0.659±0.043)显著低于对照组(0.726±0.024),而HDAC2mRNA表达量(GC有效组0.079±0.023,GC无效组0.083±0.047)显著高于对照组(0.035±0.022),治疗后,两组患者HDAC2mRNA表达量(
Objective To evaluate expression of HDAC2 in peripheral blood mononuclear cells(PBMCs)from glucocorticoid-resistant versus glucocorticoid-sensitive patients with sudden sensorineural hearing loss and identi-ty the relationship between the level of HDAC2 and glucocorticoid insensitivity.Methods PBMCs were collected from10 patients with deviation of nasal septum (control group)and 20 sudden sensorineural hearing loss patients be-fore and after intratympanic methylprednisolone for 10 days.We divided the SSNHL patients into 2 groups (GC sensitive group and GC insensitive group)according to their hearing recovery.Real time PCR and HDAC2 Assay Kit were used to detect the expression level of HDAC2 mRNA and HDAC2 activity in PBMCs.The data were analyzed with SPSS 17.0 software.ResuIts Before intratympanic methylprednisolone,the level of HDAC2 activity were sig-nificantly depressed in SSNHL patients,while the HDAC2 mRNA expressing much higher than the control group. The expression lev